the therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced...
TRANSCRIPT
![Page 1: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/1.jpg)
The therapeutic effect and molecular mechanism
of astragalosides against -amyloid–induced
neurotoxicity in primary cortical neurons
SPEAKER: LI-SHENG CHANG
DATE: 104.02.13
COMMENTATOR: KAO-CHANG LIN, CHING-PING CHANG
![Page 2: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/2.jpg)
Introduction
Alzheimer’s Disease (AD):
Dementia is a brain disorder that seriously affects a person’s
memory, thinking, and reasoning skills.
About 5 percent of men and women ages 65 to 74 have
Alzheimer’s disease, and nearly half of those age 85 and older
may have the disease.
Alzheimer’s & Dementia 2014; 10:e47-e92
![Page 3: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/3.jpg)
The prevalence of Alzheimer’s disease
http://www.tada2002.org.tw/tada_know_02.html衛生福利部
![Page 4: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/4.jpg)
hippocampus
Alzheimer’s Disease (AD)
Amyloid Plaques
Neurofibrillary Tangles
Alzheimer’s association (http://www.alz.org)Adv Med Sci. 2014; 60(1):76-82.
![Page 5: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/5.jpg)
Hypothesis of the development of Alzheimer's disease
Neurosci Biobehav Rev. 2015; 49C:71-81.
![Page 6: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/6.jpg)
The formation of -amyloid
Nature Reviews Neuroscience 2008; 9, 532-544
![Page 7: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/7.jpg)
The aggregation of tau protein
Nature Reviews Neuroscience 2008; 9, 532-544
![Page 8: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/8.jpg)
Reproducing plaques and neurofibrillary tangles in transgenic mice
Nature Reviews Neuroscience 2008; 9, 532-544
![Page 9: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/9.jpg)
Behavioural tests used to assess memory functions in AD mouse models
Nature Reviews Neuroscience 2008; 9, 532-544
![Page 10: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/10.jpg)
The therapy of Alzheimer’s disease
• 乙醯膽鹼抑制劑( Cholinesterase inhibitors):
目前改善阿茲海默氏症患者知能藥物的主流。目前有 donepezil (愛憶欣 ) 及 Exelon(憶思能 ) 與 Riminyl三種。
• 乙醯膽鹼的前身 (Acetylcholine precursors):有幾個小規模的 lecithin及 choline的臨床試驗,顯示無效。
• 尼古丁接受體促效劑( Nicotinic cholinergic receptor
agonists):
兩個臨床試驗,其中一個發現尼古丁對學習能力有幫助,但記憶則沒有改善。• Muscarinic cholinergic agonists:
因為乙醯膽鹼的腸胃及暈厥的副作用,所以臨床試驗沒再繼續。
![Page 11: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/11.jpg)
To investigate a possible therapeutic candidate
of drug for the treatment of Alzheimer's disease
![Page 12: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/12.jpg)
黃耆總皂苷( Astragalus membranaceus)
• 多年生草本,豆科植物莢膜黃耆或蒙古黃耆之乾燥根
• 產於中國華北、東北、內蒙古和西北,主產於山西、黑龍
江、遼寧、河北等省
• 有益氣固表、斂汗固脫、托瘡生肌、利水消腫之功效
• 用于治療氣虛乏力,中氣下陷,表虛自汗,血虛萎黃,內
熱消渴,慢性腎炎,蛋白尿,糖尿病等。炙黃耆益氣補中,
生用固表托瘡。
![Page 13: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/13.jpg)
有效成分
•以現代科學分析技術已知具有:
1.多醣類( astragalan,黃耆多醣)
2.三萜皂苷類( astragalosides,黃耆總皂苷)
3.黃酮類、胺基酸、酚酸、蔗糖、微量元素等成分
J. Agric. Food Chem., 50:4861-4866, 2002.
![Page 14: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/14.jpg)
Pharmacological activities of Astragalus
• Astragaloside IV can protect the myocardial cells of rats from damage caused by lack of oxygen, and increase the content and activity of superoxide dismutase (SOD) in the cytoplasm.
• Astragaloside IV can improve fructopyranose-induced metabolic syndrome in rats by increasing levels of nitric metabolite and cyclic guanosine monophosphate, which manifested as reduction in blood pressure and improvement in insulin resistance.
• Astragaloside IV acted on HepG2 cells transfected with hepatitis-B virus, and secretion of hepatitis-B surface antigen, hepatitis-Be antigen as well as serum HBV DNA levels were reduced.
Clin Exp Pharmacol Physiol 2009;36(4):351-357.
Molecules 2011;16(5):3896-3907
Biol PharmBull 2009;32(1):132-135
![Page 15: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/15.jpg)
Astragaloside IV Alleviates Early Brain Injury Following Experimental Subarachnoid Hemorrhage in Rats
subarachnoid hemorrhage (SAH)
Int J Med Sci. 2014; 11(10):1073-81.
grade 1, no subarachnoid blood (scores=0);grade 2, minimal subarachnoid clots (scores=1);grade 3, moderate subarachnoid clots with recognizable arteries (scores=2) grade 4, blood clots covering all arteries (scores=3).
![Page 16: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/16.jpg)
Astragaloside in Alzheimer’s disease
SK-N-SH cells
PLoS One. 2014; 9(6):e98866.
![Page 17: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/17.jpg)
Aim
To investigate the protective effects of
astragalosides on A-induced primary
cortical neuron death
![Page 18: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/18.jpg)
Astragalosides reverse A-induced neuron cell death
A25-35
Control 0 50 100 200 400
Cell
via
bil
ity (
% )
0
20
40
60
80
100
120
ug/ml AST
##
##
#
****
# :P<0.05 VS.Control.
:P<0.05 VS.A 25-35.
![Page 19: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/19.jpg)
Cell morphology after AST treatment against on Ab-induced injury
Control Aβ 25-35 Aβ+50 ug/ml AST
Aβ+100 g/ml AST Aβ+200 g/ml AST Aβ+400 g/ml AST
200x
![Page 20: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/20.jpg)
Astragalosides reverse A-induced DNA fragmentation
100 bp marker
C 0 50 100 200 400
Aβ25-35
ug/ml AST
![Page 21: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/21.jpg)
Astragalosides reverses A-induced caspase 3 activation
Caspase-3
β-actin
Control 0 50 100 200 400ug/ml AST
Aβ 25-35
1 25.6 6.6 3 1.6 2.4
![Page 22: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/22.jpg)
Summary (1)
Astragalosides exerts an inhibitory effect on A-
Induced apoptosis in primary cortical neuron
![Page 23: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/23.jpg)
Astragalosides inhibits A-induced tau hyper-phosphorylation
Total-Tau
β-actin
C 0 50 100 200 400
Aβ 25-35
ug/ml AST
p-Tau ( S199/202 )
1 17.5 3.86.3 3.2 3.8
1 1.14.9 0.80.7 1.2
p-Tau ( T231 )
Synaptophysin
0.21 0.7 0.6 0.8 0.9
![Page 24: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/24.jpg)
Astragalosides restores A-induced synapse loss
Control
MAP2 Synaptophysin DAPI Meraged
Aβ
Aβ+ 50 ug/ml AST
Aβ+ 200 ug/ml AST
Aβ+ 100 ug/ml AST
Aβ+ 400 ug/ml AST
![Page 25: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/25.jpg)
Summary (2)
AST inhibits A-induced tau hyperphosphorylation
and maintains neuronal synapse
![Page 26: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/26.jpg)
Future work
PI3K/Akt
β-amyloid deposition
Apoptosis
AST
β -cateninMitochondrial
dysfunctionNeurofibrillary
tangles
Tau hyperphosphorylationERK
ActivationInhibition
??
![Page 27: The therapeutic effect and molecular mechanism of astragalosides against -amyloid–induced neurotoxicity in primary cortical neurons SPEAKER: LI-SHENG](https://reader034.vdocuments.site/reader034/viewer/2022050819/56649ec65503460f94bd146c/html5/thumbnails/27.jpg)
Thank you for your attention